High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study

1. Loarce-Martos, J.
2. García-Fernández, A.
3. López-Gutiérrez, F.
4. García-García, V.
5. Calvo-Sanz, L.
6. del Bosque-Granero, I.
7. Terán-Tinedo, M.A.
8. Boteanu, A.
9. Bachiller-Corral, J.
10. Vázquez-Díaz, M.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1007/S00296-020-04699-X GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus